Kunihiro Yamaoka

22PUBLICATIONS
62CO-AUTHORS
Toxicology (incl. clinical toxicology)Rheumatology and arthritisMedical infection agents (incl. prions)AutoimmunityRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 28, 2026
Comparative Safety Analysis of Targeted Synthetic and Biologic Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis: A Nationwide Cohort Study in Japan.

|Jun 26, 2026
2024 Update of the Asia-Pacific League of Associations for Rheumatology (APLAR) Recommendations for Rheumatoid Arthritis Management.

|Apr 09, 2026
Expression of MS4A4A on synovial infiltrating macrophages is a hallmark of rheumatoid arthritis and reflects disease severity.

Hirotomo Asakura, Yu Matsueda, Keisuke Ikeda

|Mar 13, 2026
Predictive value of interferon regulatory factor 5 nuclear translocation in B cells for disease activity and flare in systemic lupus erythematosus: a prospective observational cohort study.

Yoshiro Kanayama, Tatsuma Ban, Go R Sato

|Feb 09, 2026
Risk Factors for Major Adverse Cardiovascular Events, Malignancies, and Serious Infections With Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of a 3-Year J-Post-Marketing Surveillance.

Kunihiro Yamaoka, Masato Hoshi, Yutaka Endo

|Jun 05, 2025
A retrospective chart review to explore the efficacy and safety of switching to peficitinib in Japanese patients with rheumatoid arthritis and inadequate response to biologic disease-modifying antirheumatic drugs.

Kunihiro Yamaoka, Junichi Kondo, Toshinori Furuya

Pageof 4

Frequent Collaborators

6 joint publications

Yoshiya Tanaka

3 joint publications

Yoshiyuki Arinuma

2 joint publications

Hideto Kameda

2 joint publications

Tsutomu Takeuchi